The University of Washington's Northwest Research Group on Aging is partnering with Area Agencies on Aging (AAA) in Washington and Oregon to complete this translational investigation of RDAD (Reducing Disabilities in Alzheimer's Disease). RDAD is an evidence-based program with demonstrated efficacy in helping older adults with dementia maintain physical function and remain physically and mentally healthy. This study asks two questions: 1) Can AAA partners successfully translate and implement RDAD, and 2) Is AAA implementation of RDAD effective in producing desired outcomes among agencies, providers, and older adults with dementia and their family members. This study is being conducted in Washington and Oregon states.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
510
Exercise training for caregiver and care recipient. Behavioral modification training for caregiver.
University of Washington
Seattle, Washington, United States
Minutes of exercise per week
Caregivers will track the number of minutes per week the care recipients engage in exercise recommended by the coach.
Time frame: Change from baseline in number of minutes of exercise each week during treatment phase of study, weeks 7-12
Restricted Activity Days
Restricted Activity Days measures how much the participant cut down his/her usual activities in the previous two weeks because of injury or illness and how many days the participant stayed in bed in the previous two weeks because of injury or illness.
Time frame: Baseline
Restricted Activity Days
Restricted Activity Days measures how much the participant cut down his/her usual activities in the previous two weeks because of injury or illness and how many days the participant stayed in bed in the previous two weeks because of injury or illness.
Time frame: Change from Baseline to Pre-Treatment (6 weeks)
Restricted Activity Days
Restricted Activity Days measures how much the participant cut down his/her usual activities in the previous two weeks because of injury or illness and how many days the participant stayed in bed in the previous two weeks because of injury or illness.
Time frame: Change from Baseline to Post- Treatment 1 (13 weeks)
Restricted Activity Days
Restricted Activity Days measures how much the participant cut down his/her usual activities in the previous two weeks because of injury or illness and how many days the participant stayed in bed in the previous two weeks because of injury or illness.
Time frame: Change from Baseline to Post-Treatment 2 (30 weeks)
Restricted Days of Activity
Restricted Activity Days measures how much the participant cut down his/her usual activities in the previous two weeks because of injury or illness and how many days the participant stayed in bed in the previous two weeks because of injury or illness.
Time frame: Change from Baseline to 13 Month Follow-Up
Independence/Residential Status
All participants will be in independent living situations at baseline. Any move from independent living to a care facility will be documented throughout the 13 month study.
Time frame: Change from Baseline to 13 Month Follow-Up
Revised Memory and Behavior Problem Checklist (RMBPC)
Checklist rates 24 care recipient behaviors for frequency of occurrence and caregiver reaction.
Time frame: Baseline
Revised Memory and Behavior Problem Checklist (RMBPC)
Checklist rates 24 care recipient behaviors for frequency of occurrence and caregiver reaction.
Time frame: Change from Baseline to Pre-Treatment (6 weeks)
Revised Memory and Behavior Problem Checklist (RMBPC)
Checklist rates 24 care recipient behaviors for frequency of occurrence and caregiver reaction.
Time frame: Change from Baseline to Post-Treatment 1 (13 weeks)
Revised Memory and Behavior Problem Checklist (RMBPC)
Checklist rates 24 care recipient behaviors for frequency of occurrence and caregiver reaction.
Time frame: Change from Baseline to Post-Treatment 2 (30 weeks)
Revised Memory and Behavior Problem Checklist (RMBPC)
Checklist rates 24 care recipient behaviors for frequency of occurrence and caregiver reaction.
Time frame: Change from Baseline to 13 Month Follow-Up
Quality of Life-AD
This 13-item measure is specifically designed for individuals with dementia and focuses on quality of life domains identified as important for cognitively impaired older adults.
Time frame: Baseline
Quality of Life-AD
This 13-item measure is specifically designed for individuals with dementia and focuses on quality of life domains identified as important for cognitively impaired older adults.
Time frame: Change from Baseline to Pre-Treatment (6 weeks)
Quality of Life-AD
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
This 13-item measure is specifically designed for individuals with dementia and focuses on quality of life domains identified as important for cognitively impaired older adults.
Time frame: Change from Baseline to Post-Treatment 1 (13 weeks)
Quality of Life-AD
This 13-item measure is specifically designed for individuals with dementia and focuses on quality of life domains identified as important for cognitively impaired older adults.
Time frame: Change from Baseline to Post-Treatment 2 (30 weeks)
Quality of Life-AD
This 13-item measure is specifically designed for individuals with dementia and focuses on quality of life domains identified as important for cognitively impaired older adults.
Time frame: Change from Baseline to 13 Month Follow-Up
CES-D
This 20-item scale that assesses depression in caregivers.
Time frame: Baseline
CES-D
A 20-item scale that assesses depression in caregivers.
Time frame: Change from Baseline to Pre-Treatment (6 weeks)
CES-D
A 20-item scale that assesses depression in caregivers.
Time frame: Change from Baseline to Post-Treatment 1 (13 weeks)
CES-D
A 20-item scale that assesses depression in caregivers.
Time frame: Change from Baseline to Post-Treatment 2 (30 weeks)
CES-D
A 20-item scale that assesses depression in caregivers.
Time frame: Change from Baseline to 13 Month Follow-Up